These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26037048)

  • 21. Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies.
    Xiong Y; Bensoussan D; Decot V
    Transfus Med Rev; 2015 Oct; 29(4):259-67. PubMed ID: 26282736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research advance on adaptive immune therapy with natural killer cells--review].
    Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):798-802. PubMed ID: 20561454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.
    Nguyen S; Béziat V; Norol F; Uzunov M; Trebeden-Negre H; Azar N; Boudifa A; Bories D; Debré P; Vernant JP; Vieillard V; Dhédin N
    Transfusion; 2011 Aug; 51(8):1769-78. PubMed ID: 21332732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.
    Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Jang YJ; Kang M; Yeom YI; Lee JL; Kim DY; Lee YS; Kang YA; Jeon M; Seol M; Lee JH; Lee JH; Kim HJ; Yun SC; Lee KH
    Biol Blood Marrow Transplant; 2014 May; 20(5):696-704. PubMed ID: 24525278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell adoptive immunotherapy: Coming of age.
    Baggio L; Laureano ÁM; Silla LMDR; Lee DA
    Clin Immunol; 2017 Apr; 177():3-11. PubMed ID: 26883680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can NK cells be a therapeutic target in human cancer?
    Chan CJ; Andrews DM; Smyth MJ
    Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adoptive transfer of allogeneic antigen-specific T cells.
    Riddell SR; Bleakley M; Nishida T; Berger C; Warren EH
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):9-12. PubMed ID: 16399578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.
    Veluchamy JP; Kok N; van der Vliet HJ; Verheul HMW; de Gruijl TD; Spanholtz J
    Front Immunol; 2017; 8():631. PubMed ID: 28620386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.
    Sangiolo D; Mesiano G; Carnevale-Schianca F; Piacibello W; Aglietta M; Cignetti A
    Expert Opin Biol Ther; 2009 Jul; 9(7):831-40. PubMed ID: 19463075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12/15/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation.
    Hüber CM; Doisne JM; Colucci F
    Eur J Immunol; 2015 Jun; 45(6):1727-35. PubMed ID: 25778912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.
    Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Kang YL; Lee JH; Lee JH; Kim DY; Lee JL; Park HS; Choi EJ; Lee YS; Kang YA; Jeon M; Seol M; Baek S; Yun SC; Kim HJ; Lee KH
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2065-2076. PubMed ID: 27530969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
    Shi J; Tricot G; Szmania S; Rosen N; Garg TK; Malaviarachchi PA; Moreno A; Dupont B; Hsu KC; Baxter-Lowe LA; Cottler-Fox M; Shaughnessy JD; Barlogie B; van Rhee F
    Br J Haematol; 2008 Dec; 143(5):641-53. PubMed ID: 18950462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.
    Velardi A; Ruggeri L; Mancusi A; Aversa F; Christiansen FT
    Curr Opin Immunol; 2009 Oct; 21(5):525-30. PubMed ID: 19717293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.
    Yong CS; John LB; Devaud C; Prince MH; Johnstone RW; Trapani JA; Darcy PK; Kershaw MH
    Oncotarget; 2016 Jun; 7(23):34582-98. PubMed ID: 27153556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
    Cytotherapy; 2006; 8(6):554-8. PubMed ID: 17148031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
    J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.